Patients
EnGeneIC’s phase I trial is being conducted at three centres in Melbourne: the Peter MacCallum Cancer Centre, the Austin Hospital and the Royal Melbourne Hospital.

Phase I trials are not suitable for all patients with cancer. If you are interested in participating in this study please discuss this with your oncologist.

We regret that the hospitals will be unable to respond directly to requests from patients. They are only able to review patients for the trial after referral from an oncologist.

You or your oncologist may also obtain more detailed information about the study from EDVinfo@petermac.org
or by ringing (03) 9656 5224.

New Targeted Delivery System for Cancer
Fighting Drugs
BREAKTHROUGH
EnGeneIC’s landmark publication, “Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or cytotoxic drugs”, in July’s issue of Nature Biotechnology journal.
read more | watch video

employment
No positions available
at this time.